HRSA Requires the Most Granular Quality Reporting in Primary Care. FQHCs Have the Fewest Analytics Resources.
A FQHC CMO typically manages UDS reporting, PCMH recognition, 340B program compliance, sliding fee scale documentation, HRSA Section 330 grant compliance, and health equity measure stratification with zero to one dedicated analysts. The Uniform Data System (UDS) requires annual reporting to HRSA across patient demographics (Table 3A by payer, Table 3B by age/sex), staffing (Table 5), and clinical quality measures (Table 6B). Table 6B alone includes 24 clinical quality measures requiring patient-level data stratified by race, ethnicity, and language.
HRSA launched UDS+ in 2023 — a FHIR-based supplemental reporting layer that requires FQHCs to transmit standardized FHIR resources rather than aggregate counts. UDS+ adds enhanced quality metrics beyond traditional UDS Table 6B measures. Most FQHC analytics systems were built for traditional UDS aggregate reporting and have no FHIR data pipeline.
Generic BI tools don't know the difference between UDS Table 3A payer categories and standard insurance buckets. They can't calculate the sliding fee scale tier distribution or verify that fee discount documentation meets HRSA requirements. Vizier is built around the FQHC data model — from HRSA payer categorization to 340B eligible patient identification.
FQHC-Specific Analytics Capabilities
FQHC Reporting Requirements
FQHCs submit the Uniform Data System (UDS) annual report to HRSA by February 15 each year covering the prior calendar year. UDS tables include patient demographics stratified by payer type (Table 3A) and age/sex (Table 3B), staffing by provider type and FTE (Table 5), and 24 clinical quality measures stratified by race, ethnicity, and primary language (Table 6B). HRSA uses UDS data for grant compliance monitoring, and UDS performance affects HRSA STAR ratings that are public.
The Quality Improvement Fund (QI Fund) and quality bonus payments under section 330(l) are tied to UDS performance improvement year-over-year. FQHCs that demonstrate meaningful improvement in clinical quality measures receive additional grant funding. The stakes of UDS reporting are therefore both compliance and financial — but most FQHCs lack mid-year visibility into their projected UDS performance until the annual reporting crunch begins.
Mid-Year UDS Visibility — Not Just an Annual Reporting Scramble
Upload your EHR and billing data, track UDS Table 6B performance in real time, identify health equity gaps by race and ethnicity, and calculate 340B savings — all without a dedicated data analyst.